Analysis of the effect of strengthening the quality management of centralized intravenous drug allocation on drug safety in children
强化静脉用药集中调配质量管理对小儿用药安全的效果分析

摘要

目的 探究强化静脉用药集中调配质量管理对小儿用药安全的效果。方法 将本院在2023年1月-2024年1月期间收治的100例患儿为研究对象，该期间采取强化静脉用药集中调配质量管理，设为实验组。将2021年1月-2022年1月期间收治的100例患儿设为参考组，该期间未采取强化静脉用药集中调配质量管理。对两组用药问题发生情况、用药不良反应及投诉发生率进行对比。结果 实验组用药问题发生率低于参考组（P＜0.05）。实验组用药不良反应发生率及投诉发生率均低于参考组（P＜0.05）。结论 强化静脉用药集中调配质量管理可有助于降低小儿用药问题发生率、用药不良反应发生率及投诉发生率，确保患儿的用药安全。此种方法值得推广。

Abstract

Objective To explore the effect of strengthening the quality management of centralized intravenous drug allocation on drug safety in children.
Methods 100 cases of children admitted to our hospital from January 2023 to January 2024 were taken as the research objects. During this period, we strengthened the quality management of centralized allocation of intravenous drugs, and set them as the experimental group. 100 children admitted from January 2021 to January 2022 were set as the reference group. During this period, the quality management of centralized intravenous drug allocation was not strengthened. Compare the occurrence of medication problems, adverse drug reactions, and complaint rates between two groups.
Results The incidence of medication problems in the experimental group was lower than that in the reference group (P<0.05). The incidence of adverse drug reactions and complaints in the experimental group was lower than that in the reference group (P<0.05).
Conclusion   Strengthening the quality management of centralized intravenous drug allocation can help reduce the incidence of drug use problems, adverse drug reactions and complaints in children, and ensure the safety of drug use in children. This method is worth promoting.